학술논문

Controlled release of an endostatin peptide using chitosan nanoparticles.
Document Type
Article
Source
Chemical Biology & Drug Design. Sep2017, Vol. 90 Issue 3, p417-424. 8p.
Subject
*CHITOSAN
*NANOPARTICLES
*ANTINEOPLASTIC agents
*PEPTIDES
*ENDOSTATIN
*GELATION
*SURFACE charges
Language
ISSN
1747-0277
Abstract
Whereas several anticancer peptides are in different stages of clinical development, their administration is limited by the fast elimination from the systemic circulation. Peptide loading on nano-carriers can pave the way for their future application. We have recently indicated that a disulfide loop rather than a Zn-binding loop improves the anti-angiogenic and antitumor activities of the N-terminal fragment of endostatin. In this study, chitosan nanoparticles (CS NPs) are used for the controlled release of the engineered peptide. Loading of the peptide into CS NPs using the ionic gelation method was confirmed by FTIR and resulted in final particle size, poly-dispersity index and surface charge of 186.5 ± 24.0 nm, 0.26 ± 0.02 and 20.1 ± 0.4 mV respectively. The SEM morphological analysis revealed spherical particles with an average size of 80 ± 5 nm. Peptide loading studies revealed that CS NPs are able to adsorb the peptide as ~70%. The release measurements indicated an initial burst release by 49% after 2 hr and complete release after 80 hr. According to in vitro studies, the loaded peptide was much more toxic for endothelial cells than different cancer cell lines. These results underscore the promise of CS NPs as therapeutics nanosystems and open a perspective for improving the clinical applications of peptide drugs. [ABSTRACT FROM AUTHOR]